Multi-center, phase 3, open label, 26-week trial investigating the safety, tolerability, and efficacy of Transcon hGH administered once weekly in children with growth hormone deficiency
This study will assess safety and tolerability of an experimental drug in children with growth hormone deficiency (GHD).
Those eligible to participate in this study include:
Interactive Campus Map
2500 North State Street
Jackson, MS 39216
General Information: 601-984-1000
Patient Appointments: 888-815-2005